venlafaxine hydrochloride

Generic: venlafaxine hydrochloride

Labeler: westminster pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name venlafaxine hydrochloride
Generic Name venlafaxine hydrochloride
Labeler westminster pharmaceuticals, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Westminster Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 69367-417
Product ID 69367-417_f5372620-d970-4c76-b148-35264d890c1a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205468
Listing Expiration 2026-12-31
Marketing Start 2025-11-18

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69367417
Hyphenated Format 69367-417

Supplemental Identifiers

RxCUI
808744 808748
UPC
0369367417099 0369367418096
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name venlafaxine hydrochloride (source: ndc)
Generic Name venlafaxine hydrochloride (source: ndc)
Application Number ANDA205468 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-09)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-30)
source: ndc

Packages (2)

69367-417-09 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-09) 69367-417-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-30)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

Venlafaxine Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f5372620-d970-4c76-b148-35264d890c1a", "openfda": {"upc": ["0369367417099", "0369367418096"], "unii": ["7D7RX5A8MO"], "rxcui": ["808744", "808748"], "spl_set_id": ["349308ef-2caf-4fec-b428-56ae06c6771d"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-09)", "package_ndc": "69367-417-09", "marketing_start_date": "20251118"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69367-417-30)", "package_ndc": "69367-417-30", "marketing_start_date": "20251118"}], "brand_name": "Venlafaxine Hydrochloride", "product_id": "69367-417_f5372620-d970-4c76-b148-35264d890c1a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "69367-417", "generic_name": "Venlafaxine Hydrochloride", "labeler_name": "Westminster Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Venlafaxine Hydrochloride", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA205468", "marketing_category": "ANDA", "marketing_start_date": "20251118", "listing_expiration_date": "20261231"}